ARTICLE
Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy
Late efficacy and implications for patient selection
Bernard Iung, MDa,
Eric Garbarz, MDa,
Pierre Michaud, MDa,
Abdallah Mahdhaoui, MDa,
Steeven Helou, MDa,
Bruno Farah, MDa,
Patricia Berdah, MDa,
Pierre-Louis Michel, MDa,
Yasuhiro Makita, MDa,
Bertrand Cormier, MDa,
Philippe Luxereau, MDa and
Alec Vahanian, MDa
a Cardiology Department, Tenon Hospital, Paris, France
Manuscript received April 2, 1999;
revised manuscript received November 2, 1999,
accepted December 15, 1999.
Reprint requests and correspondence: Dr. Bernard Iung, Department of Cardiology, Hopital Bichat, 47 Rue Henri Huchard, 75018 Paris, France bernard.iung001{at}wanadoo.fr
OBJECTIVES
The results of percutaneous mitral commissurotomy were assessed in patients with restenosis after surgical commissurotomy.
BACKGROUND
Balloon dilation is feasible in patients with restenosis after surgical commissurotomy, but little is known about its late efficacy.
METHODS
We studied 232 patients who had undergone percutaneous mitral commissurotomy a mean of 16 ± 8 years after surgical commissurotomy. Mean age was 47 ± 14 years; 81 patients (35%) had valve calcification. All patients had restenosis with bilateral commissural fusion as assessed by echocardiography. Technical failure occurred in 9 patients and the procedure used a single balloon in 7 patients, a double balloon in 95, and the Inoue balloon in 121.
RESULTS
Complications were death in 1 patient (0.4%) and mitral regurgitation >2/4 in 10 (4%); 191 patients (82%) had good immediate results (valve area 1.5 cm2 without regurgitation >2/4). Predictors of poor immediate results in multivariate analysis were older age (p < 0.001), lower initial valve area (p = 0.01) and the use of the double-balloon technique (p = 0.015). In the 175 patients who underwent follow-up, 8-year survival without operation and in New York Heart Association class I or II was 48 ± 5%, and 58 ± 6% after good immediate results. In this latter group, poor late functional results were predicted by higher cardiothoracic index (p < 0.0001), previous open-heart commissurotomy (p = 0.05) and lower final valve area (p < 0.0001) in a multivariate Cox model.
CONCLUSIONS
Percutaneous mitral commissurotomy is safe and provides good immediate results in selected patients with restenosis after surgical commissurotomy. After good immediate results, the conditions of more than half of the patients remained improved at 8 years, enabling reoperation to be deferred.
|
Abbreviations and Acronyms
| | CHC | = closed-heart commissurotomy | | EBDA | = effective balloon dilating area | | NYHA | = New York Heart Association | | OHC | = open-heart commissurotomy | | PMC | = percutaneous mitral commissurotomy |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper
CHAPTER 21 Valvular Heart Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J.,
January 26, 2007;
(2007)
ehl428v1.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian and I. F. Palacios
Percutaneous Approaches to Valvular Disease
Circulation,
April 6, 2004;
109(13):
1572 - 1579.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian
VALVE DISEASE: Balloon valvuloplasty
Heart,
February 1, 2001;
85(2):
223 - 228.
[Full Text]
|
 |
|
|